Mirae Asset Global Investments
AKBA icon

Mirae Asset Global Investments’s Akebia Therapeutics AKBA Stock Holding History

Mirae Asset Global Investments’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-60,533
Closed -$623K – 437
2015
Q2 		$623K Sell
60,533
-25,959
-30% -$221K 0.02% 358
2015
Q1 		$961K Buy
+86,492
New +$921K 0.03% 306

Other funds holding AKBA

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mirae Asset Global Investments's AKBA Position: Q3 2015 in Review

Mirae Asset Global Investments sold out of Akebia Therapeutics (AKBA) in Q3 2015, closing a stake of 60,533 shares — an estimated $623K sold.

Mirae Asset Global Investments first reported a position in AKBA in Q1 2015 and held it in 2 quarters. The position peaked at $961K in Q1 2015. 82 funds tracked by Wall St. Rank hold AKBA as of Q3 2015.

  • Mirae Asset Global Investments reported no remaining Akebia Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Mirae Asset Global Investments sold 60,533 Akebia Therapeutics shares in Q3 2015, an estimated $623K.
  • Mirae Asset Global Investments first reported a position in Akebia Therapeutics in Q1 2015 and held it in 2 quarters.
  • Mirae Asset Global Investments's Akebia Therapeutics position peaked at $961K in Q1 2015.
  • 82 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2015.

Based on Mirae Asset Global Investments's 13F filing for Q3 2015, filed 12 Nov 2015.